Aarkstore Enterprise -------king Pharmaceuticals, Inc. (kg) - Financial And Strategic Analysis Revi

King Pharmaceuticals, Inc. (King) is a pharmaceutical company engaged in the development and commercialization of branded prescription pharmaceutical products and animal health products. It develops therapies and technologies to the markets including neuroscience, hospital and acute care medicines. Its branded prescription pharmaceuticals consisting of nueroscience products, hospital products and legacy brands. Its animal health products include medicated feed additives (MFAs) and water-soluble therapeutics primarily for poultry, cattle, and swine.

King Pharmaceuticals, Inc. Key Recent Developments

May 05, 2010: King Pharmaceuticals Reports Net Income Of $4.5 Million For Q1 2010

Apr 15, 2010: King Pharmaceuticals Introduces New EpiPen Auto-Injectors

Mar 17, 2010: King's Subsidiaries Finalize Civil Settlement With US Department Of Justice

Feb 09, 2010: King Pharmaceuticals Names Two New Members To Its Board Of Directors

Oct 27, 2009: King Pharmaceuticals Licenses Rights To Cyanokit In US

This comprehensive SWOT analysis of King Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information please contact :

http://www.aarkstore.com/reports/King-Pharmaceuticals-Inc-KG-Financial-and-Strategic-Analysis-Review-51811.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by:

POST COMMENT

Why Is It Important To Get Public Liability Insurance In Australia? Women Of Today Start Realizing Your Full Potential History and growth of women's ready-to-wear industry Instant money-Face financial crisis easily Considerations For Buying An Outdoor Fireplace Trend Setter Collection Of Kids Clothes Pitfalls Of Dealing With Insurance Companies And Contractors Sell Engagement Rings To Make Money The Superb Tourist Destination Tips On Finding A Ideal Break In Mexico Optimising Your PPC Account Escape On Holidays To Turkey This Christmas What Is The Lowest Price For Medifast? Finding My Wedding Shoes